Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen-Jianpi Decoction in HCC and Colorectal Cancer
NCT03189992Phase 1Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jan 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Bushen-Jianpi Decoction in hepatocellular carcinoma (HCC) and colorectal cancer (CRC) (4 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Complete patient recruitment at 24 months. Status: unknown.
02
Drugs
Bushen-Jianpi Decoction
03
Conditions
hepatocellular carcinoma (HCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03189992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189992.